Dual targeting of CCR2+ monocytes and neutrophils enhances anti-tumor immunity
Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, Marco Carretta, Majken Storm Siersbæk, Kevin James Baker, Marie‐Louise Thorseth, Mie Linder Hübbe, Mads Hald Andersen, Lars Grøntved, Daniel Hargbøll Madsen
This study shows that targeting both CCR2+ monocytes and neutrophils improves anti-tumor immunity by reducing tumor growth and enhancing CD8+ T cell infiltration.
bioRxiv · May 15, 2026 · PreprintCancer Biology